table of content
1 Introduction to Research & Analysis Reports
1.1 Non-small Cell Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-small Cell Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-small Cell Lung Cancer Therapeutics Overall Market Size
2.1 Global Non-small Cell Lung Cancer Therapeutics Market Size: 2022 VS 2031
2.2 Global Non-small Cell Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-small Cell Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Non-small Cell Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Non-small Cell Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Non-small Cell Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-small Cell Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-small Cell Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Non-small Cell Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-small Cell Lung Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-small Cell Lung Cancer Therapeutics Market Size Markets, 2022 & 2031
4.1.2 Alimta
4.1.3 Iressa
4.1.4 Avastin
4.1.5 Tarceva
4.1.6 Zykadia
4.1.7 Tagrisso
4.1.8 Xalkori
4.1.9 Cyramza
4.1.10 Opdivo
4.1.11 Alecensa
4.2 By Type - Global Non-small Cell Lung Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2024-2031
4.2.3 By Type - Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share, 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-small Cell Lung Cancer Therapeutics Market Size, 2022 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Non-small Cell Lung Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2024-2031
5.2.3 By Application - Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Non-small Cell Lung Cancer Therapeutics Market Size, 2022 & 2031
6.2 By Region - Global Non-small Cell Lung Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Non-small Cell Lung Cancer Therapeutics Revenue, 2024-2031
6.2.3 By Region - Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2031
6.3.2 US Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.3.3 Canada Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.3.4 Mexico Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2031
6.4.2 Germany Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.3 France Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.4 U.K. Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.5 Italy Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.6 Russia Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.7 Nordic Countries Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.4.8 Benelux Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2031
6.5.2 China Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.5.3 Japan Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.5.4 South Korea Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.5.5 Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.5.6 India Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2031
6.6.2 Brazil Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.6.3 Argentina Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-small Cell Lung Cancer Therapeutics Revenue, 2019-2031
6.7.2 Turkey Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.7.3 Israel Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.7.4 Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
6.7.5 UAE Non-small Cell Lung Cancer Therapeutics Market Size, 2019-2031
7 Non-small Cell Lung Cancer Therapeutics Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.1.4 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.2.4 Novartis Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Novartis Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.3.4 AstraZeneca Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Roche Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.6.4 Pfizer Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Pfizer Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.7.4 Eli Lilly Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Major Product Offerings
7.8.4 Sanofi Non-small Cell Lung Cancer Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
